Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric…

By S. Al-Batran, R. Hofheinz, C. Pauligk, H. Kopp, G. Haag, K. Luley, J. Meiler, N. Homann, S. Lorenzen, H. Schmalenberg and 30 more. The Lancet Oncology, 2016

629 citations recorded by the source corpus.

Subfields: Gastroenterology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/0051e2fa88f1c01c61e56e3ea64d08b7c5bf5b12